Literature DB >> 15577524

Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation.

Shawn M McGee1, Deanna N McGee, Michael B McGee.   

Abstract

A healthy 31-year-old male abstinent from drug abuse during his recent incarceration developed slurred speech, a severe headache, and left-sided hemiparesis prior to his eventual death 9.5 hours after inhalation of methamphetamine. On postmortem examination, inspection of the brain revealed bilateral subarachnoid hemorrhage, with a prominent intralobar hemorrhage centered within the right frontal cerebral hemisphere. No evidence of vasculitis, infarction, intraventricular hemorrhage, or ruptured aneurysm could be observed. While this is not the first report of a methamphetamine-related stroke, this report describes the autopsy findings of an intracerebral hemorrhage secondary to methamphetamine abuse on autopsy and compares the findings and antemortem history to previously reported methamphetamine cerebral vascular deaths.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577524     DOI: 10.1097/01.paf.0000137206.16785.2f

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  20 in total

Review 1.  The implications of substance misuse for intravenous conscious sedation practice.

Authors:  J Noone; E Critchley; P Cullingham; P Coulthard; A Saksena
Journal:  Br Dent J       Date:  2015-02       Impact factor: 1.626

2.  Racial disparities in methamphetamine-associated intracerebral hemorrhage.

Authors:  Kazuma Nakagawa; Megan A Vento; Marissa M Ing; Todd B Seto
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

Review 3.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

4.  Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Authors:  Dionne E Swor; Matthew B Maas; Sandeep S Walia; David P Bissig; Eric M Liotta; Andrew M Naidech; Kwan L Ng
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

5.  Psychostimulant-related deaths among former inmates.

Authors:  Susan Calcaterra; Patrick Blatchford; Peter D Friedmann; Ingrid A Binswanger
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

6.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

7.  Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia.

Authors:  Hitoshi Maeda; Bao-Li Zhu; Yasumori Bessho; Takaki Ishikawa; Li Quan; Tomomi Michiue; Dong Zhao; Dong-Ri Li; Ayumi Komatsu
Journal:  Forensic Sci Med Pathol       Date:  2008-02-07       Impact factor: 2.007

8.  Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Elena Shumay; Frank Telang; Peter K Thanos; David Alexoff
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

9.  Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

Authors:  Jennifer Treweek; Sunmee Wee; George F Koob; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

Review 10.  At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.

Authors:  Matthew M Grinsell; Victoria F Norwood
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.